Immunic Inc. buy tamam
Start price
25.03.20
/
50%
€7.50
Target price
04.11.21
€25.00
Performance (%)
17.93%
End price
05.11.21
€8.85
Summary
This prediction ended on 05.11.21 with a price of €8.85. The BUY prediction by tamam finished with a performance of 17.93%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunic Inc. | -10.060% | -10.060% | -18.132% | -31.383% |
| iShares Core DAX® | -1.665% | -10.870% | -0.717% | 41.869% |
| iShares Nasdaq 100 | -3.766% | -5.147% | 13.412% | 70.295% |
| iShares Nikkei 225® | -2.803% | -11.299% | 25.461% | 45.956% |
| iShares S&P 500 | -2.299% | -4.801% | 8.938% | 54.178% |
Comments by tamam for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) announces positive top-line data from its phase 2 EMPhASIS trial of lead asset, IMU-838, the selective oral DHODH inhibitor, in patients with relapsing-remitting multiple sclerosis (RRMS).
In the thread Trading Immunic Inc.
Die von tamam gewählte maximale Laufzeit wurde überschritten